Some U.S. pharmacies are scrambling to fill estradiol transdermal patch prescriptions as demand for the menopause treatment continues to soar following the Trump administration’s decision to remove what it determined was an outdated cancer warning.
“Manufacturers have been unable to provide sufficient supply of hormone replacement therapies [HRT] over the last several weeks,” CVS pharmacy spokeswoman Roslyn Guarino told The Epoch Times March 9.
